WebAurinia Pharmaceuticals is a fully integrated biopharmaceutical company focused on delivering therapies to treat targeted patient populations that are impacted by serious diseases with a high unmet medical need. In January 2024, the Company introduced LUPKYNIS® (voclosporin), the first FDA-approved oral therapy for the treatment of adult ... WebNov 18, 2024 · BitNile Holdings, Inc. is estimated to report earnings on 11/18/2024. The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. Our vendor, Zacks ...
Verizon ends 2024 with strong wireless service revenue and EPS …
WebMar 28, 2024 · 1.BitNile Has Paid Off Its Secured Debt. On March 28, BitNile released a statement saying that the company had paid off senior secure notes in the amount of $66 million. According to CFO Kenneth ... WebApr 27, 2024 · And GAAP diluted earnings per share was a dollar $1.68, up 54.1% year over year. Adjusted net income was $477 million for the quarter, up 12.2% year over year, and adjusted diluted earnings per ... birth of a new earth
Investor Relations :: Aurinia Pharmaceuticals Inc. (AUPH)
WebOct 10, 2024 · BitNile’s preliminary revenue for the nine months ended September 30, 2024 increased by $54.6 million, or 123%, to $99.1 million, from $44.6 million for the nine … WebFeb 18, 2024 · Fourth Quarter and Full-Year 2024 Highlights. For the three months ended December 31, 2024, DraftKings reported revenue of $473 million, an increase of 47% compared to $322 million during the same period in 2024. Fourth quarter 2024 revenue exceeded the guidance previously provided by the Company during its third quarter … WebDec 31, 2024 · Revenues. Revenues by segment for the year ended December 31, 2024 and 2024 were as follows: Total revenue increased by $28.5 million, or 120%, to $52.4 … darby high school tennis camp